Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2020 Filed Aug 21, 2020 20:05 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
SaleCommon Stock | 7,500 | $26.87 | $201,525.00 |
DisclosureSEC source: 0001125345-20-000129 · wf-form4_159804028658626.xml · nonDerivative · entry 2 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.54 to $27.27. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staffof the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 20:05 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
Exercise / conversionCommon Stock | 7,500 | $7.51 | $56,325.00 |
DisclosureSEC source: 0001125345-20-000129 · wf-form4_159804028658626.xml · nonDerivative · entry 1 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · derivative · entry 7 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 489 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · derivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 489 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,000 | $25.63 | $76,890.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.71 to $26.15. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 1,000 | $25.14 | $25,140.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.72 to $25.55. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 4,000 | $1.51 | $6,040.00 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 489 | $25.13 | $12,288.57 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.01 to $25.21. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:12 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 489 | $0.94 | $459.66 |
DisclosureSEC source: 0001125345-20-000118 · wf-form4_159597054259461.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC |
Peters Jeffrey StuartGeneral Counsel
|
SaleCommon Stock | 202 | $30.00 | $6,060.00 |
DisclosureSEC source: 0001125345-20-000116 · wf-form4_159406714373071.xml · nonDerivative · entry 1 Peters Jeffrey Stuart · CIK 0001706903 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,100 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 3,100 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,100 | $30.00 | $93,000.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:25 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 3,100 | $1.51 | $4,681.00 |
DisclosureSEC source: 0001125345-20-000115 · wf-form4_159406709977419.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 20:24 UTC |
Eck Stephen L.Chief Medical Officer
|
GrantEmployee stock option (right to buy) · Derivative | 200,000 | $28.87 Strike: $28.87 | $5,774,000.00 |
DisclosureSEC source: 0001125345-20-000114 · wf-form4_159406705696583.xml · derivative · entry 1 Eck Stephen L. · CIK 0001669041 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-07-01 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 500 | $28.49 | $14,245.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| June 24, 2020 Filed Jun 25, 2020 20:57 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000108 · wf-form4_159311863890623.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 500 | $26.59 | $13,295.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.52 to $26.66. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staffof the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000100 · wf-form4_159061217316217.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 21, 2020 23:44 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,500 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001125345-20-000098 · wf-form4_159010466198723.xml · derivative · entry 3 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,647 Underlying: Common Stock · 7,500 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| May 20, 2020 Filed May 21, 2020 23:44 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
SaleCommon Stock | 7,500 | $25.30 | $189,750.00 |
DisclosureSEC source: 0001125345-20-000098 · wf-form4_159010466198723.xml · nonDerivative · entry 2 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.86 to $25.78. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 20, 2020 Filed May 21, 2020 23:44 UTC |
Spitznagel ThomasSr VP, BPD & Manufacturing
|
Exercise / conversionCommon Stock | 7,500 | $7.51 | $56,325.00 |
DisclosureSEC source: 0001125345-20-000098 · wf-form4_159010466198723.xml · nonDerivative · entry 1 Spitznagel Thomas · CIK 0001675464 · Sr VP, BPD & Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:37 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000091 · wf-form4_158957503190453.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:38 UTC |
STUMP DAVID CDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000093 · wf-form4_158957507216789.xml · derivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:37 UTC |
SIEGEL JAY PHILIPDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000092 · wf-form4_158957505251632.xml · derivative · entry 1 SIEGEL JAY PHILIP · CIK 0001722857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:37 UTC |
HURWITZ EDWARDDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000090 · wf-form4_158957501009925.xml · derivative · entry 1 HURWITZ EDWARD · CIK 0001211840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:36 UTC |
Galbraith KennethDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000089 · wf-form4_158957498839484.xml · derivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:36 UTC |
Ferrante Karen JeanDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000088 · wf-form4_158957496520267.xml · derivative · entry 1 Ferrante Karen Jean · CIK 0001598502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:36 UTC |
Costa Paulo FDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.97 | $0.00 |
DisclosureSEC source: 0001125345-20-000087 · wf-form4_158957493660773.xml · derivative · entry 1 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant. Read SEC document |
| May 14, 2020 Filed May 19, 2020 01:21 UTC |
Bonvini EzioSr VP, Research & CSO
|
GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-20-000096 · wf-form4_158985129585734.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest as to 50% of the total shares on May 14, 2021 and 50% on May 14, 2022, subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: The RSUs will vest as to 50% of the total shares on May 14, 2021 and 50% on May 14, 2022, subject to the reporting person's continued employment with the Company. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 7,532 | $1.51 Strike: $1.51 | $11,373.32 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · derivative · entry 8 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 Underlying: Common Stock · 7,532 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.94 Strike: $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · derivative · entry 7 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,489 Underlying: Common Stock · 500 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,532 | $25.00 | $88,300.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 6 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 3,000 | $20.00 | $60,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 5 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 1,000 | $15.00 | $15,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 500 | $10.00 | $5,000.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 7,532 | $1.51 | $11,373.32 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 7, 2020 20:22 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000075 · wf-form4_158888294604504.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:11 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,000 | $0.94 Strike: $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000059 · wf-form4_158715426128615.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 Underlying: Common Stock · 6,000 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:11 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 6,000 | $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000059 · wf-form4_158715426128615.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:09 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,000 | $0.94 Strike: $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000046 · wf-form4_158447577366938.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 6,000 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:09 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 6,000 | $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-20-000046 · wf-form4_158447577366938.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 20:15 UTC |
Koenig ScottDirector · President and CEO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 133,163 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000044 · wf-form4_158413051474478.xml · derivative · entry 2 Koenig Scott · CIK 0001587514 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 133,163 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 20:15 UTC |
Koenig ScottDirector · President and CEO
|
Exercise / conversionCommon Stock | 133,163 | $0.94 | $125,173.22 |
DisclosureSEC source: 0001125345-20-000044 · wf-form4_158413051474478.xml · nonDerivative · entry 1 Koenig Scott · CIK 0001587514 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 20:39 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,473 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-20-000038 · wf-form4_158378636028779.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 4,473 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 20:39 UTC |
Karrels JamesSVP, CFO and Secretary
|
Exercise / conversionCommon Stock | 4,473 | $0.94 | $4,204.62 |
DisclosureSEC source: 0001125345-20-000038 · wf-form4_158378636028779.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 500 | $0.94 Strike: $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 500 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
SaleCommon Stock | 500 | $10.84 | $5,420.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:44 UTC |
Risser Eric BlasiusSr VP & Chief Business Officer
|
Exercise / conversionCommon Stock | 500 | $0.94 | $470.00 |
DisclosureSEC source: 0001125345-20-000011 · wf-form4_158232147185800.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.